Literature DB >> 29508139

Axillary web syndrome assessment using a self-assessment questionnaire: a prospective cohort study.

F Baggi1, Luiz Felipe Nevola Teixeira2, S Gandini3, M C Simoncini1, E Bonacossa1, F Sandrin1, M Sciotto Marotta1, G Lanni1, P Dadda1, D Colpani1, A Luini4.   

Abstract

BACKGROUND: Surgical procedure for breast cancer is not without its side effects and one such side effect is axillary web syndrome (AWS), characterized by palpable fibrotic-like cords in the operated arm. As physical evaluation is the only gold standard method used, our study aims to assess the incidence and early detection of AWS with a self-assessment questionnaire.
METHODS: From July 2013 to July 2014, 370 breast cancer patients were enrolled. AWS incidence was 51.1%, with 94.1% onset in the first 4 weeks after surgery; 43.5% of the patients did not recover in the first 8 weeks. Univariate analysis showed that BMI (P < 0.001), age (P < 0.001), educational level (P = 0.01), and exercise frequency in the eighth week of follow-up (P < 0.001) were significantly associated with the AWS detection, and multivariate analyses confirmed that younger patients (age < 50) have significantly higher AWS detection (OR = 2.38 (95%CI 1.53, 3.71) and that BMI is associated with AWS, with normal weight patients (BMI ≤ 25) having a significantly greater AWS detection with an odds ratio of 2.11 (95%CI 1.33, 3.36).
CONCLUSION: Our findings indicated that the incidence of AWS is high in breast cancer patients, particularly in the first month after surgery. Not all patients achieved recovery during our 8 week follow-up, suggesting that evaluation and treatment should be longer. Double AWS detection was found for patients who were younger (age < 50) and with normal weight.

Entities:  

Keywords:  Breast neoplasms; Breast reconstruction; Lymph node dissection; Physiotherapy; Rehabilitation

Mesh:

Year:  2018        PMID: 29508139     DOI: 10.1007/s00520-018-4123-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  24 in total

1.  Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

Authors:  Bernard Fisher; Jong-Hyeon Jeong; Stewart Anderson; John Bryant; Edwin R Fisher; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-08-22       Impact factor: 91.245

2.  Axillary Web Syndrome after Sentinel Node Biopsy.

Authors:  Fatih Aydogan; Ahmet Korkut Belli; Semih Baghaki; Kagan Karabulut; Gulgun Tahan; Cihan Uras
Journal:  Breast Care (Basel)       Date:  2009-08-11       Impact factor: 2.860

3.  Movement, Function, Pain, and Postoperative Edema in Axillary Web Syndrome.

Authors:  Linda A Koehler; Anne H Blaes; Tuffia C Haddad; David W Hunter; Alan T Hirsch; Paula M Ludewig
Journal:  Phys Ther       Date:  2015-05-14

4.  Incidence and risk factors for axillary web syndrome after breast cancer surgery.

Authors:  Anke Bergmann; Valéria Vasconcellos Mendes; Ricardo de Almeida Dias; Blenda do Amaral E Silva; Maria Giseli da Costa Leite Ferreira; Erica Alves Nogueira Fabro
Journal:  Breast Cancer Res Treat       Date:  2011-10-11       Impact factor: 4.872

5.  Axillary web syndrome: nature and localization.

Authors:  O Leduc; M Sichere; A Moreau; J Rigolet; A Tinlot; S Darc; F Wilputte; J Strapart; T Parijs; A Clément; T Snoeck; F Pastouret; A Leduc
Journal:  Lymphology       Date:  2009-12       Impact factor: 1.286

6.  Axillary web syndrome is not a risk factor for lymphoedema after 10 years of follow-up.

Authors:  Bárbara Reis Wariss; Rejane Medeiros Costa; Ana Carolina Padula Ribeiro Pereira; Rosalina Jorge Koifman; Anke Bergmann
Journal:  Support Care Cancer       Date:  2016-10-04       Impact factor: 3.603

7.  Complication rates in patients with negative axillary nodes 10 years after local breast radiotherapy after either sentinel lymph node dissection or axillary clearance.

Authors:  A Gabriella Wernicke; Michael Shamis; Kulbir K Sidhu; Bruce C Turner; Yevgenyia Goltser; Imraan Khan; Paul J Christos; Lydia T Komarnicky-Kocher
Journal:  Am J Clin Oncol       Date:  2013-02       Impact factor: 2.339

Review 8.  Exercise interventions for upper-limb dysfunction due to breast cancer treatment.

Authors:  Margaret L McNeely; Kristin Campbell; Maria Ospina; Brian H Rowe; Kelly Dabbs; Terry P Klassen; John Mackey; Kerry Courneya
Journal:  Cochrane Database Syst Rev       Date:  2010-06-16

Review 9.  Barriers to rehabilitation following surgery for primary breast cancer.

Authors:  Andrea L Cheville; Julia Tchou
Journal:  J Surg Oncol       Date:  2007-04-01       Impact factor: 3.454

Review 10.  Upper body pain and functional disorders in patients with breast cancer.

Authors:  Michael D Stubblefield; Nandita Keole
Journal:  PM R       Date:  2013-12-19       Impact factor: 2.298

View more
  4 in total

1.  Axillary web syndrome among Chilean women with breast cancer: incidence and possible predisposing factors.

Authors:  Karol Ramírez-Parada; Diana Garay-Acevedo; Williams Mella-Abarca; Militza Petric-Guajardo; César Sánchez-Rojel; Margaret L McNeely; Ivana Leao-Ribeiro; Rodrigo Fernández-Verdejo
Journal:  Support Care Cancer       Date:  2019-11-25       Impact factor: 3.603

2.  Five-Year Cumulative Incidence of Axillary Web Syndrome and Comparison in Upper Extremity Movement, Function, Pain, and Lymphedema in Survivors of Breast Cancer With and Without Axillary Web Syndrome.

Authors:  Linda Koehler; Amanda Day; David Hunter; Anne Blaes; Tufia Haddad; Ryan Shanley
Journal:  Arch Phys Med Rehabil       Date:  2022-04-06       Impact factor: 4.060

3.  Randomised clinical trial of a manual therapy programme to reduce the evolution time of axillary web syndrome in women affected by breast cancer: study protocol.

Authors:  Jesús Baltasar González Rubino; Maria Jesus Vinolo-Gil; Cristina García Muñoz; Rocío Martín-Valero
Journal:  BMJ Open       Date:  2022-09-21       Impact factor: 3.006

4.  Lymphoscintigraphic Investigations for Axillary Web Syndromes.

Authors:  Mirela Mariana Roman; Romain Barbieux; Christine Eddy; Clarence Karler; Isabelle Veys; Assaf Zeltzer; Nele Adriaenssens; Olivier Leduc; Pierre Bourgeois
Journal:  Lymphat Res Biol       Date:  2021-11-22       Impact factor: 2.349

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.